Literature DB >> 12197800

Determinants of mother-to-infant human immunodeficiency virus 1 transmission before and after the introduction of zidovudine prophylaxis.

.   

Abstract

BACKGROUND: Randomized controlled trials have demonstrated that zidovudine therapy decreases the mother-to-infant transmission of human immunodeficiency virus 1 (HIV-1). Data from large observational studies may provide further important findings on the effectiveness at the population level of combined treatments in decreasing transmission.
OBJECTIVE: To evaluate time trends in prophylactic interventions and the determinants of transmission both before and after the introduction of antiretroviral prophylaxis, and in treated and untreated mother-infant pairs after 1995. DESIGN AND
SETTING: Analysis of prospective data on 3770 children born to HIV-1-infected women between 1985 and 1999 and reported to the Italian Register for HIV Infection in Children. MAIN OUTCOME MEASURES: Logistic regression random effects models were used to estimate crude and adjusted odds ratios for several factors potentially influencing vertical transmission for 2 periods-1985 through 1995 (January 1, 1985, through December 31, 1995) and 1996 through 1999 (January 1, 1996, through December 31, 1999), and between treated and untreated children after 1995.
RESULTS: The transmission rate was 15.5% in the 1985-1995 period and 5.8% in the 1996-1999 period. By 1999, prophylactic interventions had greatly increased. Antiretroviral treatment (ART) usage was 89.9%, (55.1% combination ART) and the elective cesarean delivery rate was 81.3%. In multivariate analysis, only elective cesarean delivery was associated with a lower risk of mother-to-infant transmission before 1995. After 1995, nonbreastfeeding and receipt of ART were protective whereas elective cesarean delivery was not significantly protective in multivariate analysis. Transmission risk was reduced by 76% with an incomplete zidovudine regimen, 88% with a complete regimen, and 93% when the mother received combination ART. In the 1996-1999 period, the transmission rate for nonbreastfeeding mother-infant pairs was 8.6% with elective cesarean delivery, 4.4% with any ART, and 2.4% with these interventions combined.
CONCLUSION: Prophylactic interventions, and in particular ART, reduced perinatal HIV-1 transmission at a population level in Italy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12197800     DOI: 10.1001/archpedi.156.9.915

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN: 1072-4710


  4 in total

1.  Italian consensus statement on paediatric HIV infection.

Authors:  C Giaquinto; M Penazzato; R Rosso; S Bernardi; O Rampon; P Nasta; A Ammassari; A Antinori; R Badolato; G Castelli Gattinara; A d'Arminio Monforte; M De Martino; A De Rossi; P Di Gregorio; S Esposito; F Fatuzzo; S Fiore; A Franco; C Gabiano; L Galli; O Genovese; V Giacomet; A Giannattasio; C Gotta; A Guarino; A Martino; F Mazzotta; N Principi; M B Regazzi; P Rossi; R Russo; M Saitta; F Salvini; S Trotta; A Viganò; G Zuccotti; G Carosi
Journal:  Infection       Date:  2010-06-01       Impact factor: 7.455

Review 2.  Elective cesarean section for women living with HIV: a systematic review of risks and benefits.

Authors:  Caitlin E Kennedy; Ping T Yeh; Shristi Pandey; Ana P Betran; Manjulaa Narasimhan
Journal:  AIDS       Date:  2017-07-17       Impact factor: 4.177

3.  Characteristics and management of HIV-1-infected pregnant women enrolled in a randomised trial: differences between Europe and the USA.

Authors:  Marie-Louise Newell; Sharon Huang; Simona Fiore; Claire Thorne; Laurent Mandelbrot; John L Sullivan; Robert Maupin; Isaac Delke; D Heather Watts; Richard D Gelber; Coleen K Cunningham
Journal:  BMC Infect Dis       Date:  2007-06-20       Impact factor: 3.090

4.  The second generation of HIV-1 vertically exposed infants: a case series from the Italian Register for paediatric HIV infection.

Authors:  Carmelina Calitri; Clara Gabiano; Luisa Galli; Elena Chiappini; Carlo Giaquinto; Wilma Buffolano; Orazio Genovese; Susanna Esposito; Stefania Bernardi; Maurizio De Martino; Pier-Angelo Tovo
Journal:  BMC Infect Dis       Date:  2014-05-20       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.